Diversified Healthcare Trust (NASDAQ: DHC) is a Real Estate company (REIT - Healthcare Facilities) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Diversified Healthcare Trust had a Maz Rating of 2.37 out of 5 (C, Hold), ranked against the other companies in its sector. Its strongest factor then was Momentum (4.58), among the strongest in its sector; its weakest was Profitability (1.54), below most of its sector. The other factors: Valuation 2.82 (valued in line with its sector); Financial Health 2.02 (below most of its sector); Growth 1.85 (below most of its sector). The current rating is for members: log in to see it.
At $7.16, Diversified Healthcare Trust trades at 1.2x sales and 1.1x book value, with an EV/EBITDA of 13.2. Over the last twelve months it generated about $1.5B of revenue and a net loss of $156M. It runs a gross margin of -4.1%, an operating margin of -2.1% and a net margin of -10.3%. It shows return on equity of -9.5%, return on invested capital of -0.7% and a free cash flow yield of -2.7%. On the balance sheet: a debt-to-equity ratio of 1.58 and a current ratio of 8.99. Over the past 52 weeks the share price ranged from $4.34 to $9.66, with a beta of 2.29.
Diversified Healthcare Trust pays a dividend yielding 0.56%.
18 Wall Street analyst ratings cover the stock: 4 Buy, 11 Hold and 3 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.